Emergency Respiratory Pathogens, e.g. COVID19: Coronavirus Disease; Middle east Respiratory Syndrome Coronavirus Infection: MERS COV

B34.2/U07.1

*Notifiable medical condition.


Note: Consult most recent guidelines from National Department of Health/ NICD.

DESCRIPTION

Middle East Respiratory Syndrome (MERS) is a viral respiratory illness caused by Middle East Respiratory Syndrome Coronavirus (MERS-CoV). Individuals with MERS-CoV present with a wide spectrum of clinical presentation ranging from asymptomatic infection to acute upper respiratory illness, and rapidly progressing lower respiratory illness; respiratory failure, septic shock and multi-organ failure resulting in death.

A typical presentation of MERS includes:

  • fever (>38°C), chills or rigors, cough, shortness of breath

Presentation may include:

  • hemoptysis, sore throat, myalgias, diarrhoea, vomiting, abdominal pain

Complications:

  • severe pneumonia
  • acute renal failure
  • ARDS
  • refractory hypoxaemia

GENERAL MEASURES

All suspected, probable cases and contacts must be discussed and managed in consultation with the regional virologist or infectious diseases specialist at the referral centre.

In addition cases should be discussed with the Centre for Respiratory Diseases of the National Institute for Communicable Diseases (NICD).

Tel: 011 386 6392/ 011 3866390 , Outbreak hotline: 082 883 9920


COVID-19 HOTLINE NUMBERS

Clinicians: 080011131

Public: 080002999

http://www.nicd.ac.za/ ; https://sacoronavirus.co.za/


Transfer of patients will only occur once all relevant arrangements have been made to limit further exposure to a potential contagious and life threatening agent.

Droplet precautions should be added to the standard precautions. Airborne precautions should be applied when performing aerosol-generating procedures.

ISOLATE SUSPECTED SYMPTOMATIC CASES AT ALL TIMES.

If MERS coronavirus is suspected, isolate patient to limit further exposure.

MANAGEMENT

Treatment

Treatment is supportive.

No antiviral agents or vaccines are currently available.

Management of contact: consult with NICD and isolate contact.

Record and follow-up all patient contacts.

Prevention

Handwashing and the careful disposal of materials infected with nasal secretions. Antiseptic/disinfectant solutions:choroxylenol, benzalkonium chloride, and cetrimide. Chlorhexidine has been shown to be ineffective.

REFERRAL

All cases after consultation with infectious diseases and NICD.